Everyone is talking about AI models.
But in scientific research and drug discovery, the model is only one piece of the puzzle.
A powerful LLM without the right context is like a world-class horse without a rider—it has tremendous capability, but limited direction.
At WeDaita, we've learned that the real challenge isn't simply choosing the best model. It's harnessing the model with the right scientific context.
That's why we've built over 200 domain-specific tools that connect AI agents to more than 40 public and proprietary biomedical data sources, enabling researchers to go beyond chat and perform real scientific work.
That means connecting AI to:
🔬 Scientific literature and publications
🧬 Genomics and expression data
🧪 Drug discovery databases
🧫 Protein, pathway, and biological knowledge
🏥 Clinical and disease intelligence
📊 Proprietary organizational data
⚙️ Multi-step workflows and specialized tools
This is why we built WeDaita around a modular AI agent architecture. Models provide reasoning, but context provides understanding. Together, they enable researchers to ask better questions, synthesize knowledge faster, and make more informed decisions.
As foundation models continue to improve, I believe the competitive advantage will increasingly come from how effectively organizations can integrate and harness their unique scientific context.
The future of AI in drug discovery isn't just bigger models.
It's smarter context.
--------------------
♻️ Know someone who may benefit from accelerating drug discovery with AI?
➡️ Feel free to share: https://lnkd.in/esuPivNr
----------------------
#AI #DrugDiscovery #LifeSciences #Biotech #GenerativeAI #ScientificAI #ResearchInformatics #LLM #AgenticAI #WeDaita